Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Other Non-Current Liabilities (2020 - 2026)

Evotec SE's (EVO) quarterly Other Non-Current Liabilities came in at $1.6 million in Q2 2026, up 17.64% year-over-year from $1.3 million in Q2 2025, and down 0.72% quarter-over-quarter from $1.6 million in Q1 2026.

Analysis

Evotec SE (EVO) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Evotec SE has disclosed Other Non-Current Liabilities across 7 years of filings, most recently posting $1.6 million for Q2 2026.

  • In Q2 2026, Other Non-Current Liabilities rose 17.64% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (up 17.64% YoY), while the FY2025 annual figure was $1.9 million, up 36.45% from the prior year.
  • Other Non-Current Liabilities came in at $1.6 million for Q2 2026 at Evotec SE, down from $1.6 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $25.1 million in Q3 2024 to a low of -$404414.5 in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $2.9 million, with a median of $1.3 million recorded in 2025.
  • Year-over-year, Other Non-Current Liabilities jumped 340.45% in 2023 and retreated 6.05% in 2024.
  • Over 5 years, Other Non-Current Liabilities stood at $996781.7 in 2022, then jumped by 49.71% to $1.5 million in 2023, then retreated by 6.05% to $1.4 million in 2024, then soared by 42.39% to $2.0 million in 2025, then decreased by 22.15% to $1.6 million in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.6 million in Q2 2026, $1.6 million in Q1 2026, and $2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn
6 Evotec SE 642.83 Mn 216.96 Mn -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.55 Mn
Mar 31, 2026 1.57 Mn
Dec 31, 2025 2.00 Mn
Jun 30, 2025 1.32 Mn
Mar 31, 2025 1.30 Mn
Dec 31, 2024 1.40 Mn
Sep 30, 2024 25.12 Mn
Dec 31, 2023 1.49 Mn
Jun 30, 2023 972,409.48
Dec 31, 2022 996,781.68
Sep 30, 2022 469,855.84
Jun 30, 2022 -404,414.48
Mar 31, 2022 524,131.71
Dec 31, 2021 534,234.43
Sep 30, 2021 241,753.90
Dec 31, 2020 244,419.42